Viewing Study NCT06280495


Ignite Creation Date: 2025-12-24 @ 1:59 PM
Ignite Modification Date: 2025-12-27 @ 9:41 PM
Study NCT ID: NCT06280495
Status: RECRUITING
Last Update Posted: 2025-05-30
First Post: 2024-02-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant Serplulimab & Bevacizumab With FOLFOX vs. FOLFOX Alone in RAS/BRAF WT, pMMR/MSS CRC Patients
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module